Paola Baiardi

Medicine & Life Sciences

1. Rehabilitation 100%
2. Pediatrics 96%
3. Essential Amino Acids 87%
4. Reproducibility of Results 74%
5. Rheumatoid Arthritis 74%
6. Randomized Controlled Trials 69%
7. Heart Failure 67%
8. Music Therapy 62%
9. Psychometrics 61%
10. Stroke 61%
11. Chronic Obstructive Pulmonary Disease 57%
12. Energy Metabolism 55%
13. Statistical Factor Analysis 53%
14. Hospital Information Systems 46%
15. Population 46%
16. Therapeutics 45%
17. Low Back Pain 45%
18. Child 45%
19. Muscles 45%
20. Safety 43%
21. Pharmaceutical Preparations 41%
22. Long QT syndrome type 3 39%
23. Music 39%
24. Anxiety 39%
25. Depression 38%
26. Respiratory Insufficiency 37%
27. Adalimumab 36%
28. Rare Diseases 34%
29. Rehabilitation Hospitals 34%
30. Sickness Impact Profile 34%
31. Drug Development 34%
32. Mexiletine 33%
33. Etanercept 33%
34. Methotrexate 33%
35. Italy 32%
36. Pain 32%
37. Infections 32%
38. Quality of Life 32%
39. Clodronic Acid 31%
40. Abdomen 30%
41. Off-Label Use 30%
42. Psychology 30%
43. Chronic Kidney Failure 29%
44. beta-Thalassemia 29%
45. Control Groups 29%
46. Advisory Committees 28%
47. Clinical Trials 28%
48. Gastrointestinal Microbiome 27%
49. Deferiprone 27%
50. Clarithromycin 27%